Search by Drug Name or NDC
NDC 23155-0840-12 diclofenac potassium 25 mg/1 Details
diclofenac potassium 25 mg/1
diclofenac potassium is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is DICLOFENAC POTASSIUM.
Product Information
| NDC | 23155-0840 |
|---|---|
| Product ID | 23155-840_38c4bcfa-d24c-4b8a-a2bc-d39a28896c76 |
| Associated GPIs | |
| GCN Sequence Number | 065429 |
| GCN Sequence Number Description | diclofenac potassium CAPSULE 25 MG ORAL |
| HIC3 | S2B |
| HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
| GCN | 27392 |
| HICL Sequence Number | 008824 |
| HICL Sequence Number Description | DICLOFENAC POTASSIUM |
| Brand/Generic | Generic |
| Proprietary Name | diclofenac potassium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | diclofenac potassium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | DICLOFENAC POTASSIUM |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210078 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0840-12 (23155084012)
| NDC Package Code | 23155-840-12 |
|---|---|
| Billing NDC | 23155084012 |
| Package | 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (23155-840-12) |
| Marketing Start Date | 2022-11-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |